TWO · —

Synmosa Biopharma Corporation (4114.TWO) Stock

$29.40 -2.49% TWO: 4114.TWO —

—

Valuation

Metric	Value
Price	$29.40
Market Cap	$15.02B
P/E Ratio	19.00
P/B Ratio	1.84
P/S Ratio	2.25
EPS (TTM)	$1.65
52-Week High	$32.41
52-Week Low	$27.55
Dividend Yield	2.87%

Financials & Margins

Metric	Value
ROE	5.91%
ROA	3.05%
ROCE	—
Gross Margin	41.18%
Operating Margin	11.65%
Net Margin	12.38%
Debt/Equity	0.34
Current Ratio	2.03

Latest News

Alliance Entertainment (AENT) Rises After Fiscal 2026 Results: What Investors Should Know Insider Monkey · Sep 14, 2026 PrideStaff Financial Celebrates Accounting and Finance Professionals During National Staffing Employee Week PR Newswire · Sep 14, 2026 Sit out or buy now? The signal Ken Mahoney wants before jumping in TheStreet · Sep 14, 2026 CEO Coaching International Celebrates 22 Clients and Partners for Ranking on the Prestigious 2026 Inc. 5000 List PR Newswire · Sep 14, 2026 Mara Stock Tumbles, Strategy Pauses, and Bitcoin Faces a Key Test Barrons.com · Sep 14, 2026

Valuation & Return Ratios

Metric	Value
PEG Ratio	1.90
EV / EBITDA	17.08
FCF Yield	—
Quick Ratio	1.30
Interest Coverage	—
Return 1Y	-3.98%
Return 3Y	15.26%
Return 5Y	125.89%

Ownership

Insiders Held21.52%

Institutions Held4.10%

Institutions Float Held5.22%

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
1720.TWStandard Chemical & Pharmaceutical Co., Ltd.	$56.80	-1.90%	11.57	$11.32B	3.45%
1760.TWPanion & Bf Biotech Inc.	$52.10	-3.70%	21.32	$4.57B	3.33%
1795.TWLotus Pharmaceutical Co., Ltd.	$176.00	-2.76%	12.38	$46.89B	1.42%
3705.TWYungShin Global Holding Corporation	$58.90	-3.44%	16.98	$15.29B	5.25%
4105.TWOTTY Biopharm Company Limited	$80.60	-0.74%	11.58	$20.04B	5.54%

About Synmosa Biopharma Corporation

—

Synmosa Biopharma Corporation (4114.TWO) stock trades at $29.40 with a market capitalization of $15.02B. The stock is valued at a price-to-earnings (P/E) ratio of 19.00, price-to-book of 1.84, price-to-sales of 2.25. Over the past 52 weeks the stock has ranged between $27.55 and $32.41, and currently trades 9.3% below its 52-week high. It pays a dividend yielding 2.87%.

On profitability, Synmosa Biopharma Corporation generates a return on equity (ROE) of 5.91%, an operating margin of 11.65%, a net profit margin of 12.38%.

The balance sheet shows a debt-to-equity ratio of 0.34 (debt below half of shareholders' equity), a current ratio of 2.03.

4114.TWO has an average daily trading volume of 889,444 shares, a beta of -0.01, 0.51B shares outstanding.

Official website: www.synmosa.com.tw

Synmosa Biopharma Corporation (4114.TWO) — frequently asked questions

What is Synmosa Biopharma Corporation (4114.TWO) stock price today?

Synmosa Biopharma Corporation (4114.TWO) is currently trading at $29.40, down 2.49% today.

What is 4114.TWO P/E ratio?

Synmosa Biopharma Corporation's P/E ratio is 19.00. This is between 15x and 30x, around the typical market average of roughly 18-22x.

What is 4114.TWO return on equity (ROE)?

Synmosa Biopharma Corporation's return on equity (ROE) is 5.91%. ROE measures net income relative to shareholders' equity. This is below the typical market range of roughly 12-15%.

What is Synmosa Biopharma Corporation's market cap?

Synmosa Biopharma Corporation has a market capitalization of $15.02B.

Related — Stocks

USDE StablecoinX Inc. $1.00 -0.01% ALMR Alamar Biosciences, Inc. $29.72 -5.50% AVLN Avalyn Pharma Inc. $27.25 +8.52%

Related stock screens

High ROE Stocks Low P/E Stocks High Net Margin Stocks Dividend Stocks Low Debt Stocks All stock screens

Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.